Quantification of peri‐ictal magnetic resonance imaging abnormalities ( PMA ) in status epilepticus: Clinical and prognostic significance of PMA volume
Epilepsia · 31.10.2026
DOI: 10.1002/epi.70572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 31.10.2026. Verfasst von Clara Jünemann und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, Philipps-Universität Marburg, Epilepsy Center Hessen, Marburg, Germany. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Panagiota-Eleni Tsalouchidou has received research funding from the German Society for Epileptology (Otfrid- Foerster Stipendium) for the present work.
Abstract (Originalsprache)
Objective
Peri‐ictal magnetic resonance imaging (MRI) abnormalities (PMA) are increasingly recognized in patients with status epilepticus (SE), but the clinical factors influencing their occurrence and extent remain incompletely understood. We aimed to quantify PMA and investigate the associations of PMA occurrence and volume with SE duration, etiology, and mortality.
Methods
In this multicenter cohort study, comprising a retrospectively identified cohort and a prospectively recruited cohort, adult patients with SE who underwent brain MRI within 48 h of SE onset were included. PMA were identified on diffusion‐weighted imaging (DWI) and quantified using an automated postprocessing pipeline to calculate total PMA volume. Multivariable regression analyses were used to examine factors associated with PMA occurrence, extent, and mortality.
Results
Of 260 patients, 91 (35%) had PMA on DWI. In multivariable analyses, SE duration and etiology were independently associated with PMA occurrence and volume. SE lasting >60 min had higher odds of PMA (odds ratio [OR] = 3.90, 95% confidence interval [CI] = 1.79–8.82, p < .001) and significantly greater PMA volume, whereas acute triggering factors in patients with epilepsy were linked with lower odds (OR = .15, 95% CI = .05–.44, p < .001). PMA occurrence was associated with more than threefold higher odds of mortality (adjusted OR = 3.85, 95% CI = 1.55–10.24, p = .005). Each 10‐fold increase in PMA volume was associated with 43% higher odds of mortality (adjusted OR = 1.43, 95% CI = 1.14–1.80, p = .002). In a sensitivity analysis restricted to in‐hospital mortality, each 10‐fold increase in PMA volume was associated with 47% higher odds of mortality (adjusted OR = 1.47, 95% CI = 1.15–1.89, p = .002). Significance PMA extent is determined by SE duration and underlying etiology. Although MRI timing relative to SE termination could not always be determined, quantitative PMA assessment provides prognostic information beyond PMA presence alone, as increasing PMA volume is associated with progressively higher mortality. These findings support quantitative PMA burden as a potential imaging biomarker of SE severity and adverse outcome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, Philipps-Universität Marburg, Epilepsy Center Hessen, Marburg, Germany.
- Department of Neurology, Faculty of Medicine, Philipps-Universität Marburg, Marburg, Germany.
- Department of Neurology, Christian Doppler University Hospital, Center for Cognitive Neuroscience, member of European Reference Network EpiCARE, Paracelsus Medical University of Salzburg, Salzburg, Austria.
- Neuroscience Institute, Christian Doppler University Hospital, Center for Cognitive Neuroscience, Paracelsus Medical University of Salzburg, Salzburg, Austria.
- Department of Neuroradiology, Philipps Universität Marburg, Marburg, Germany.
- Department of Neuroradiology, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria.
ORCID-Profile: Clara Jünemann, Marcus Belke, Emily Falk, Pilar Bosque-Varela, Anna Wieacker, Leona Möller, Lukas Machegger, Eugen Trinka, Giorgi Kuchukhidze, Susanne Knake, Panagiota-Eleni Tsalouchidou
Förderung
- Panagiota-Eleni Tsalouchidou has received research funding from the German Society for Epileptology (Otfrid- Foerster Stipendium) for the present work
Zitieren
APA
Jünemann, C., Belke, M., Falk, E., Bosque-Varela, P., Wieacker, A., Tabaee Damavandi, P., Möller, L., Hahn, W., Kemmling, A., Timmermann, L., Machegger, L., Trinka, E., Kuchukhidze, G., Knake, S., & Tsalouchidou, P. E. (2026). Quantification of peri‐ictal magnetic resonance imaging abnormalities ( PMA ) in status epilepticus: Clinical and prognostic significance of PMA volume. Epilepsia. https://doi.org/10.1002/epi.70572
Vancouver
Jünemann C, Belke M, Falk E, Bosque-Varela P, Wieacker A, Tabaee Damavandi P, et al. Quantification of peri‐ictal magnetic resonance imaging abnormalities ( PMA ) in status epilepticus: Clinical and prognostic significance of PMA volume. Epilepsia. 2026. doi:10.1002/epi.70572
BibTeX
@article{Jnemann2026,
author = {Jünemann, Clara and Belke, Marcus and Falk, Emily and Bosque-Varela, Pilar and Wieacker, Anna and Tabaee Damavandi, Payam and Möller, Leona and Hahn, Wiebke and Kemmling, André and Timmermann, Lars and Machegger, Lukas and Trinka, Eugen and Kuchukhidze, Giorgi and Knake, Susanne and Tsalouchidou, Panagiota-Eleni},
title = {Quantification of peri‐ictal magnetic resonance imaging abnormalities ( PMA ) in status epilepticus: Clinical and prognostic significance of PMA volume},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70572}
}
EUVIMED